1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Negative Pressure Wound Therapy (NPWT) Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Negative Pressure Wound Therapy (NPWT) Market, North America 8
3.1 Negative Pressure Wound Therapy (NPWT) Market, North America, Revenue ($m), 2015-2025 8
3.2 Negative Pressure Wound Therapy (NPWT) Market, North America, Revenue ($m), 2015-2025 10
3.3 Negative Pressure Wound Therapy (NPWT) Market, North America, Volume (Units), 2015-2025 12
3.4 Negative Pressure Wound Therapy (NPWT) Market, North America, Volume (Units), 2015-2025 14
3.5 Negative Pressure Wound Therapy (NPWT) Market, North America, Company Share by Revenue ($m), 2019 16
4 Negative Pressure Wound Therapy (NPWT) Market, Canada 17
4.1 Negative Pressure Wound Therapy (NPWT) Market, Canada, Revenue ($m), 2015-2025 17
4.1.1 NPWT Devices & Accessories Market, Canada, Revenue ($m), by Segment, 2015-2025 19
4.2 Negative Pressure Wound Therapy (NPWT) Market, Canada, Volume (Units), 2015-2025 21
4.2.1 NPWT Devices & Accessories Market, Canada, Volume (Units), by Segment, 2015-2025 23
4.3 Negative Pressure Wound Therapy (NPWT) Market, Canada, Average Price ($) , 2015-2025 25
4.4 Negative Pressure Wound Therapy (NPWT) Market, Canada, Distribution Share by Revenue ($m), 2019 26
4.5 Negative Pressure Wound Therapy (NPWT) Market, Canada, Company Share by Revenue ($m), 2019 27
5 Negative Pressure Wound Therapy (NPWT) Market, Mexico 29
5.1 Negative Pressure Wound Therapy (NPWT) Market, Mexico, Revenue ($m), 2015-2025 29
5.1.1 NPWT Devices & Accessories Market, Mexico, Revenue ($m), by Segment, 2015-2025 31
5.2 Negative Pressure Wound Therapy (NPWT) Market, Mexico, Volume (Units), 2015-2025 33
5.2.1 NPWT Devices & Accessories Market, Mexico, Volume (Units), by Segment, 2015-2025 35
5.3 Negative Pressure Wound Therapy (NPWT) Market, Mexico, Average Price ($) , 2015-2025 37
5.4 Negative Pressure Wound Therapy (NPWT) Market, Mexico, Distribution Share by Revenue ($m), 2019 38
5.5 Negative Pressure Wound Therapy (NPWT) Market, Mexico, Company Share by Revenue ($m), 2019 39
6 Negative Pressure Wound Therapy (NPWT) Market, United States 41
6.1 Negative Pressure Wound Therapy (NPWT) Market, United States, Revenue ($m), 2015-2025 41
6.1.1 NPWT Devices & Accessories Market, United States, Revenue ($m), by Segment, 2015-2025 43
6.2 Negative Pressure Wound Therapy (NPWT) Market, United States, Volume (Units), 2015-2025 45
6.2.1 NPWT Devices & Accessories Market, United States, Volume (Units), by Segment, 2015-2025 47
6.3 Negative Pressure Wound Therapy (NPWT) Market, United States, Average Price ($), 2015-2025 49
6.4 Negative Pressure Wound Therapy (NPWT) Market, United States, Distribution Share by Revenue ($m), 2019 50
6.5 Negative Pressure Wound Therapy (NPWT) Market, United States, Company Share by Revenue ($m), 2019 51
7 Overview of Key Companies in North America Negative Pressure Wound Therapy (NPWT) Market 53
7.1 Acelity Holdings, Inc. (Inactive) 53
7.1.1 Company Overview 53
7.2 Smith & Nephew Plc 53
7.2.1 Company Overview 53
7.3 Paul Hartmann AG 53
7.3.1 Company Overview 53
8 Negative Pressure Wound Therapy (NPWT) Market Pipeline Products 54
9 Recent Developments 55
9.1 Corporate Communications 55
9.1.1 Jan 24, 2020: Cardinal Health: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers 55
9.1.2 Oct 01, 2019: Sonoma Pharmaceuticals announces Management Changes 55
9.1.3 Sep 18, 2019: Invacare appoints Julie Beck to Board of Directors 55
9.1.4 Aug 07, 2019: Dean Scarborough and John Weiland to join Cardinal Health's Board of Directors 56
9.1.5 Jul 16, 2019: Cardinal Health appoints Stephen Mason to lead medical segment 57
9.1.6 Jul 08, 2019: Cardinal Health: Departure of CFO 58
9.2 Financial Announcements 58
9.2.1 Feb 14, 2020: Sonoma Pharmaceuticals reports third quarter FY 2020 financial results 58
9.2.2 Feb 10, 2020: Invacare announces financial results for the fourth quarter and full year ended December 31, 2019 59
9.2.3 Feb 06, 2020: Cardinal Health reports second quarter results for fiscal year 2020 63
9.2.4 Nov 14, 2019: Sonoma Pharmaceuticals reports second quarter FY 2020 financial results 63
9.2.5 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020 65
9.2.6 Nov 06, 2019: Invacare reports results for third quarter 2019 66
9.2.7 Aug 13, 2019: Sonoma pharmaceuticals reports first quarter FY 2020 financial results 68
9.2.8 Aug 08, 2019: Cardinal Health reports fourth quarter and full year results for fiscal year 2019 69
9.2.9 Aug 05, 2019: Invacare reports results for second quarter 2019 70
9.2.10 Jul 08, 2019: Sonoma Pharmaceuticals reports fiscal year and fourth quarter 2019 financial results 74
9.3 Government and Public Interest 75
9.3.1 Sep 05, 2019: Invacare provides business update at Baird Global Healthcare Conference 75
9.4 Legal And Regulatory 75
9.4.1 Sep 04, 2019: LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 in Cardinal Health to contact the firm 75
9.4.2 Aug 12, 2019: Lead plaintiff deadline alert: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 In Cardinal Health to contact the firm 75
9.5 Other Significant Developments 76
9.5.1 Feb 11, 2020: InfuSystem enters negative pressure wound therapy market 76
9.5.2 Jul 02, 2019: Invacare announces enhanced transformation plan progress update 77
9.5.3 May 24, 2019: NanoVibronix provides business update for the first quarter of 2019 78
9.6 Product News 79
9.6.1 Dec 02, 2019: NanoVibronix to present at two investor conferences in December 79
9.7 Research And Development 79
9.7.1 Oct 23, 2019: BioRestorative Therapies receives a second patent in Australia for its metabolic program 79
10 Appendix 81
10.1 Research Methodology 82
10.1.1 Coverage 82
10.1.2 Secondary Research 82
10.1.3 Primary Research 83
10.1.4 Market Modeling and Forecasting 84
10.1.5 Company Share Analysis 86
10.1.6 Distribution Share Analysis 86
10.1.7 Benchmarking 86
10.2 GlobalData Consulting 87
10.3 Contact Us 87
10.4 Disclaimer 88